Agilon Health, Inc. (NYSE:AGL - Get Free Report)'s share price was up 4.9% during mid-day trading on Monday . The company traded as high as $1.38 and last traded at $1.40. Approximately 1,178,316 shares traded hands during trading, a decline of 84% from the average daily volume of 7,202,739 shares. The stock had previously closed at $1.33.
Wall Street Analyst Weigh In
Several research analysts have commented on AGL shares. The Goldman Sachs Group boosted their price target on shares of Agilon Health from $2.50 to $5.00 and gave the stock a "neutral" rating in a report on Thursday, May 8th. Evercore ISI decreased their price objective on shares of Agilon Health from $5.00 to $3.00 and set an "in-line" rating for the company in a research report on Wednesday, July 9th. Jefferies Financial Group lowered their target price on shares of Agilon Health from $2.40 to $1.10 and set a "hold" rating for the company in a research note on Friday, August 15th. Benchmark dropped their target price on Agilon Health from $4.00 to $1.50 and set a "buy" rating on the stock in a report on Wednesday, August 6th. Finally, Robert W. Baird cut their price target on Agilon Health from $5.00 to $1.00 and set a "neutral" rating on the stock in a research note on Thursday, August 14th. Four analysts have rated the stock with a Buy rating, twelve have issued a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of "Hold" and an average price target of $3.07.
Read Our Latest Analysis on AGL
Agilon Health Stock Performance
The business has a 50-day moving average of $1.86 and a 200-day moving average of $2.98. The stock has a market capitalization of $578.12 million, a price-to-earnings ratio of -1.81 and a beta of 0.14.
Agilon Health (NYSE:AGL - Get Free Report) last released its quarterly earnings results on Monday, August 4th. The company reported ($0.25) EPS for the quarter, missing the consensus estimate of ($0.11) by ($0.14). Agilon Health had a negative net margin of 5.35% and a negative return on equity of 66.76%. The business had revenue of $1.39 billion during the quarter, compared to analysts' expectations of $1.47 billion. During the same quarter last year, the company earned ($0.07) EPS. The firm's revenue for the quarter was down 5.9% compared to the same quarter last year. On average, research analysts predict that Agilon Health, Inc. will post -0.59 earnings per share for the current fiscal year.
Institutional Trading of Agilon Health
Institutional investors have recently modified their holdings of the business. Wells Fargo & Company MN lifted its stake in shares of Agilon Health by 47.5% in the fourth quarter. Wells Fargo & Company MN now owns 144,763 shares of the company's stock valued at $275,000 after purchasing an additional 46,645 shares during the period. Russell Investments Group Ltd. increased its holdings in Agilon Health by 6,931.3% in the fourth quarter. Russell Investments Group Ltd. now owns 36,141 shares of the company's stock valued at $69,000 after buying an additional 35,627 shares in the last quarter. Cerity Partners LLC acquired a new stake in shares of Agilon Health during the 4th quarter valued at approximately $34,000. Renaissance Technologies LLC boosted its stake in shares of Agilon Health by 155.1% during the 4th quarter. Renaissance Technologies LLC now owns 463,300 shares of the company's stock worth $880,000 after acquiring an additional 281,700 shares in the last quarter. Finally, Raymond James Financial Inc. purchased a new stake in shares of Agilon Health during the 4th quarter worth approximately $33,000.
Agilon Health Company Profile
(
Get Free Report)
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Agilon Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Agilon Health wasn't on the list.
While Agilon Health currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.